AMRX
Price
$9.62
Change
+$0.07 (+0.73%)
Updated
Sep 5 closing price
Capitalization
3.02B
62 days until earnings call
ORGO
Price
$5.00
Change
-$0.03 (-0.60%)
Updated
Sep 5 closing price
Capitalization
634.29M
60 days until earnings call
Interact to see
Advertisement

AMRX vs ORGO

Header iconAMRX vs ORGO Comparison
Open Charts AMRX vs ORGOBanner chart's image
Amneal Pharmaceuticals
Price$9.62
Change+$0.07 (+0.73%)
Volume$1.27M
Capitalization3.02B
Organogenesis Holdings
Price$5.00
Change-$0.03 (-0.60%)
Volume$402.52K
Capitalization634.29M
AMRX vs ORGO Comparison Chart in %
Loading...
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMRX vs. ORGO commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRX is a Buy and ORGO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (AMRX: $9.62 vs. ORGO: $5.00)
Brand notoriety: AMRX and ORGO are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: AMRX: 86% vs. ORGO: 50%
Market capitalization -- AMRX: $3.02B vs. ORGO: $634.29M
AMRX [@Pharmaceuticals: Generic] is valued at $3.02B. ORGO’s [@Pharmaceuticals: Generic] market capitalization is $634.29M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.93B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMRX’s FA Score shows that 1 FA rating(s) are green whileORGO’s FA Score has 1 green FA rating(s).

  • AMRX’s FA Score: 1 green, 4 red.
  • ORGO’s FA Score: 1 green, 4 red.
According to our system of comparison, AMRX is a better buy in the long-term than ORGO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMRX’s TA Score shows that 5 TA indicator(s) are bullish while ORGO’s TA Score has 5 bullish TA indicator(s).

  • AMRX’s TA Score: 5 bullish, 4 bearish.
  • ORGO’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, ORGO is a better buy in the short-term than AMRX.

Price Growth

AMRX (@Pharmaceuticals: Generic) experienced а +0.63% price change this week, while ORGO (@Pharmaceuticals: Generic) price change was -2.91% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.08%. For the same industry, the average monthly price growth was +12.00%, and the average quarterly price growth was +86.48%.

Reported Earning Dates

AMRX is expected to report earnings on Nov 07, 2025.

ORGO is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.08% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMRX($3.02B) has a higher market cap than ORGO($634M). AMRX has higher P/E ratio than ORGO: AMRX (962.00) vs ORGO (63.75). ORGO YTD gains are higher at: 56.250 vs. AMRX (21.465). AMRX has higher annual earnings (EBITDA): 584M vs. ORGO (3.19M). ORGO (73.1M) and AMRX (71.5M) have equal amount of cash in the bank . ORGO has less debt than AMRX: ORGO (40.8M) vs AMRX (2.58B). AMRX has higher revenues than ORGO: AMRX (2.85B) vs ORGO (429M).
AMRXORGOAMRX / ORGO
Capitalization3.02B634M476%
EBITDA584M3.19M18,301%
Gain YTD21.46556.25038%
P/E Ratio962.0063.751,509%
Revenue2.85B429M665%
Total Cash71.5M73.1M98%
Total Debt2.58B40.8M6,328%
FUNDAMENTALS RATINGS
AMRX vs ORGO: Fundamental Ratings
AMRX
ORGO
OUTLOOK RATING
1..100
2621
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
75
Overvalued
PROFIT vs RISK RATING
1..100
5094
SMR RATING
1..100
9995
PRICE GROWTH RATING
1..100
4339
P/E GROWTH RATING
1..100
3111
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ORGO's Valuation (75) in the Financial Conglomerates industry is in the same range as AMRX (99) in the Pharmaceuticals Major industry. This means that ORGO’s stock grew similarly to AMRX’s over the last 12 months.

AMRX's Profit vs Risk Rating (50) in the Pharmaceuticals Major industry is somewhat better than the same rating for ORGO (94) in the Financial Conglomerates industry. This means that AMRX’s stock grew somewhat faster than ORGO’s over the last 12 months.

ORGO's SMR Rating (95) in the Financial Conglomerates industry is in the same range as AMRX (99) in the Pharmaceuticals Major industry. This means that ORGO’s stock grew similarly to AMRX’s over the last 12 months.

ORGO's Price Growth Rating (39) in the Financial Conglomerates industry is in the same range as AMRX (43) in the Pharmaceuticals Major industry. This means that ORGO’s stock grew similarly to AMRX’s over the last 12 months.

ORGO's P/E Growth Rating (11) in the Financial Conglomerates industry is in the same range as AMRX (31) in the Pharmaceuticals Major industry. This means that ORGO’s stock grew similarly to AMRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMRXORGO
RSI
ODDS (%)
Bearish Trend 1 day ago
76%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 1 day ago
87%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
78%
MACD
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
78%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 3 days ago
79%
Declines
ODDS (%)
N/A
Bearish Trend 19 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
72%
Bearish Trend 1 day ago
81%
Aroon
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DCDGX12.500.12
+0.97%
Dunham Small Cap Growth C
SSLCX55.310.09
+0.16%
DWS Small Cap Core S
FACDX56.37N/A
N/A
Fidelity Advisor Health Care A
FACGX164.02N/A
N/A
Fidelity Advisor Growth Opps C
VDSYX25.16N/A
N/A
Victory Diversified Stock Y

AMRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMRX has been loosely correlated with PAHC. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if AMRX jumps, then PAHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMRX
1D Price
Change %
AMRX100%
+0.73%
PAHC - AMRX
46%
Loosely correlated
+0.97%
VTRS - AMRX
43%
Loosely correlated
+1.65%
TEVA - AMRX
40%
Loosely correlated
+2.54%
COLL - AMRX
39%
Loosely correlated
-2.32%
ALKS - AMRX
38%
Loosely correlated
+3.53%
More

ORGO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORGO has been loosely correlated with ANIP. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ORGO jumps, then ANIP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORGO
1D Price
Change %
ORGO100%
-0.60%
ANIP - ORGO
47%
Loosely correlated
-0.68%
PRGO - ORGO
46%
Loosely correlated
-2.75%
ANIK - ORGO
33%
Loosely correlated
-1.65%
AMRX - ORGO
29%
Poorly correlated
+0.73%
GTBIF - ORGO
29%
Poorly correlated
+4.55%
More